Divi's Laboratories zooms on inking pact with global pharma company
Divi's Laboratories is currently trading at Rs 6744.00, up by 263.30 points or 4.06% from its previous closing of Rs 6480.70 on the BSE.
The scrip opened at Rs 6642.80 and has touched a high and low of Rs 6764.00 and Rs 6610.00 respectively. So far 39525 shares were traded on the counter.
The BSE group 'A' stock of face value Rs 2 has touched a 52-week high of Rs 6,764.00 on 26-May-2025 and a 52-week low of Rs 4100.70 on 24-May-2024.
Last one week high and low of the scrip stood at Rs 6764.75 and Rs 6358.30 respectively. The current market cap of the company is Rs 179032.01 crore.
The promoters holding in the company stood at 51.89%, while Institutions and Non-Institutions held 38.72% and 9.39% respectively.
Divi's Laboratories has signed long term manufacturing and supply agreement with a global pharma company. Under this agreement, the company will be manufacturing and supplying advanced intermediates as per the commercial terms agreed between the parties. The cost of capacity addition for manufacturing under this agreement is estimated to be Rs 650 to Rs 750 crore, which will be funded from the capacity reservation advance proposed to be paid by the customer phase wise under this Agreement.
Divi's Laboratories is one of the leading pharmaceutical companies in the world.
